Amicus Therapeutics vs Lutris Pharma

Amicus Therapeutics vs Lutris Pharma, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Lutris Pharma on 39/100.

Amicus Therapeutics logo
Amicus TherapeuticsBiotechnology company focused on developing treatments for rare metabolic diseases.
Try Amicus Therapeutics
Lutris Pharma logo
Lutris PharmaLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
Try Lutris Pharma

Where each one leads

Amicus Therapeutics

  • our overall score: 57/100 against 39/100

Lutris Pharma

Leads on none of the measures we hold for both companies.

At a glance

MeasureAmicus TherapeuticsLutris Pharma
What it isBiotechnology company focused on developing treatments for rare metabolic diseases.Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, MedTech, HealthTech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingBiotechBiotech
Founded20022017
HeadquartersPhiladelphia, United StatesSan Diego, United States
StatusActiveInactive

Size, funding and growth

MeasureAmicus TherapeuticsLutris Pharma
Employees625Not published
Total funding$200M$170M
Latest roundSeries DSeries A
LinkedIn followers57,431Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAmicus TherapeuticsLutris Pharma
StartupHub scoreOur 0-100 rating57/10039/100
Traction60/10040/100
Team30/10060/100
CommunityNot published15/100
Search visibility34/1002/100
Quality68/10040/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)Not published
Domain ratingLink authority, 0-10066/100Not published

Amicus Therapeutics vs Lutris Pharma: common questions

Which is better, Amicus Therapeutics or Lutris Pharma?

On our 0-100 score Amicus Therapeutics rates higher (57/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Amicus Therapeutics and Lutris Pharma compare on the numbers?

Amicus Therapeutics leads on our overall score (57/100 against 39/100).

Read the full Amicus Therapeutics review and pricing or the Lutris Pharma review and pricing. You can also browse other Amicus Therapeutics alternatives we track.